EC-Logo-2018_TM_CMYK.jpg
electroCore to Participate in the LD Micro Main Event XVI Conference
September 25, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Present at iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual Conference
September 21, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
EC-Logo-2018_TM_CMYK.jpg
electroCore Announces Second Quarter 2023 Financial Results
August 09, 2023 16:05 ET | electroCore, Inc.
Record second quarter 2023 net sales of $3.6 million, an increase of approximately 65% over second quarter 2022 Company to host a conference call and webcast today, August 9, 2023 at 4:30 PM EDT ...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Announce Second Quarter Financial Results on Wednesday, August 9
August 01, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
EC-Logo-2018_TM_CMYK.jpg
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)
July 25, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 25, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer reviewed...
EC-Logo-2018_TM_CMYK.jpg
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
July 18, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and...
EC-Logo-2018_TM_CMYK.jpg
electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC
July 13, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that ReletexTM by Reliefband,...
EC-Logo-2018_TM_CMYK.jpg
electroCore Provides Select Second Quarter 2023 Financial Guidance
July 11, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today provided select preliminary...
EC-Logo-2018_TM_CMYK.jpg
gammaCore™ Non-Invasive Vagal Nerve Stimulation Selected for Study Funded by the National Football League (NFL) and National Football League Players Association (NFLPA) on Alleviating Concussion Symptoms
July 06, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 06, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its gammaCore non-invasive...
Research Nester Logo.jpg
Epilepsy Monitoring Devices Market revenue to cross USD 622 Million by 2035, says Research Nester
July 06, 2023 05:00 ET | Research Nester
New York, July 06, 2023 (GLOBE NEWSWIRE) -- The global epilepsy monitoring devices market is estimated to grow at a CAGR of ~6% from 2023 to 2035. The market is estimated to garner a revenue of...